Impact of procalcitonin on the management of children aged 1 to 36 months presenting with fever without source: a randomized controlled trial

The American Journal of Emergency Medicine
Sergio ManzanoEdgard Delvin

Abstract

The aim of the study was to evaluate the impact of procalcitonin (PCT) measurement on antibiotic use in children with fever without source. Children aged 1 to 36 months presenting to a pediatric emergency department (ED) with fever and no identified source of infection were eligible to be included in a randomized controlled trial. Patients were randomly assigned to 1 of 2 groups as follows: PCT+ (result revealed to the attending physician) and PCT- (result not revealed). Patients from both groups also had complete blood count, blood culture, urine analysis, and culture performed. Chest radiography or lumbar puncture could be performed if required. Of the 384 children enrolled and equally randomized into the PCT+ and PCT- groups, 62 (16%) were diagnosed with a serious bacterial infection (urinary tract infection, pneumonia, occult bacteremia, or bacterial meningitis) by primary ED investigation. Ten were also found to be neutropenic (<500 x 10(6)/L). Of the remaining undiagnosed patients, 14 (9%) of 158 received antibiotics in the PCT+ group vs 16 (10%) of 154 in the PCT- group (Delta -2%; 95% confidence interval [CI], -8 to 5). A strategy to treat all patients with PCT of 0.5 ng/mL or greater with prophylactic antibiotic in thi...Continue Reading

References

Jul 17, 1998·Archives of Pediatrics & Adolescent Medicine·G M Lee, M B Harper
Sep 29, 2004·The Lancet Infectious Diseases·A M C van RossumA M Oudesluys-Murphy
Jun 29, 2005·Acta Paediatrica·Sudhin ThayyilIan G Verber
Jul 19, 2005·European Journal of Pediatrics·David TuerlinckxEddy Bodart
Aug 9, 2006·Nuclear Medicine Communications·Ayfer G GüvenYunus Emre Baysal
Aug 21, 2007·International Journal of Antimicrobial Agents·C Myers, Alain Gervaix

❮ Previous
Next ❯

Citations

May 11, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Philipp SchuetzBeat Mueller
Apr 27, 2013·Italian Journal of Pediatrics·Lydia KossivaCharalampos Tsentidis
Oct 5, 2014·The Journal of Emergency Medicine·Jasmin Tamsut EnglandStephen C Aronoff
Aug 7, 2013·Emergency Medicine Clinics of North America·Paul Ishimine
Sep 27, 2012·Annals of Emergency Medicine·David A Talan
Jul 24, 2013·Evidence-based Child Health : a Cochrane Review Journal·Vikram SabhaneyEnitan D Carrol
Jul 24, 2013·Evidence-based Child Health : a Cochrane Review Journal·Philipp SchuetzMatthias Briel
Aug 21, 2013·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·Nilam J SoniDavid L Pitrak
Jan 18, 2014·British Journal of Clinical Pharmacology·Kirsty Le DoareMike Sharland
May 1, 2016·The American Journal of Emergency Medicine·Yuri van der DoesMaarten Limper
Oct 13, 2017·The Cochrane Database of Systematic Reviews·Philipp SchuetzBeat Mueller
Jul 30, 2019·The Cochrane Database of Systematic Reviews·Vincenzo Berghella, Gabriele Saccone
Apr 4, 2013·Expert Review of Respiratory Medicine·Sebastian HaubitzPhilipp Schuetz
Oct 24, 2018·Frontiers in Pediatrics·Elles M F van de VoortRianne Oostenbrink
Dec 14, 2018·Journal of the Pediatric Infectious Diseases Society·Laura Chappell-CampbellAlan R Schroeder
Dec 3, 2013·Deutsches Ärzteblatt International·Tim Niehues
Feb 22, 2021·The Journal of Infection·B Leticia Fernandez-CarballoSabine Dittrich
Nov 23, 2021·Hospital Pediatrics·Christina S HernandezPradip P Chaudhari

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.

Bacterial Meningitis (ASM)

Bacterial meningitis continues to be an important cause of mortality and morbidity throughout the world. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacterial Meningitis

Bacterial meningitis continues to be an important cause of mortality and morbidity throughout the world. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.